Seahee Kim, Ph.D., is a biopharmaceutical industry professional with over 15 years of experience in research and business strategy. At Samsung Biologics, she leads the Organoids Technology team and played a key role in the launch of Samsung Organoids, supporting oncology research by translating advanced science into strategic, client-ready solutions. Prior to joining Samsung Biologics, she worked at the Samsung Advanced Institute of Technology. She received her PhD in Molecular Virology from Yonsei University in South Korea and completed post-doctoral training in neuroscience at Penn State University in the United States.
